Deep
Metabolic-Processes
Assessment ®
The revolutionary zero-invasive AI-native screening technology for early diagnosis and personalized medicine
DMA® device is able to identify altered biochemical reactions at the metabolic level within the human body, which are always linked to symptoms and diseases.
By analyzing these patterns, we gain valuable insights into early health indicators, enabling proactive care before diseases manifest or worsen.
By combining AI and advanced mathematical models, we developed a wide set of protocols and software, permitting us to correlate subsets of such measures to the status of specific organs the Central Nervous System (CNS) or glands.
Why studying metabolism is a game-changer
Metabolism is a complex network of chemical reactions that keeps our body functioning, enabling us to think, move and breathe. It adapts to various activities like eating, sleeping, and exercising to meet our body’s needs.
However, metabolism also responds to health challenges, shifting when organs are under stress or when inflammation occurs. These changes are often undetectable at first, as they happen at the cellular and biochemical levels without causing noticeable symptoms.
That’s where our DMA® technology comes in. It can detect these subtle changes by measuring electrical currents, capturing data at the nanoampere level.
By analyzing metabolism, we can uncover these hidden shifts, allowing for early diagnosis and intervention before conditions worsen.
The in-depth understanding of how organs function together enables us to take a holistic approach, ensuring care that is personalized, precise and effective
The more we understand an individual’s metabolic profile, the better we can:
Assess their current health status.
Uncover the connections between causes and effects.
Provide tailored interventions to achieve the best outcomes.
The science of metabolism: key reads
A multi-version approach to personalized healthcare
DMA® includes four tailored versions for screening, diagnostics, performance, and monitoring. We’re currently launching DMA® Screening, our core solution, for early detection and personalized, AI-powered health insights.
DMA® Screening
Advanced metabolic analysis for early detection and prevention. Ideal for health checkups, personalized diets, and proactive care.
Users: Molecular biologists, physiologists
End Users: Individuals seeking early health insights
Output: Reports on metabolic patterns linked to potential health risks.
DMA® Diagnostic
Targets disease-specific metabolic patterns to support accurate diagnosis and treatment planning.
Users: Physicians and healthcare professionals
End Users: Patients with suspected conditions
Output: Disease-specific metabolic profiles with diagnostic probabilities.
DMA® Performance
Optimizes physical and cognitive performance through metabolic insights, ideal for high-stress professions.
Users: Sports doctors, psychologists, fitness experts
End Users: Athletes, emergency workers, executives
Output: Recommendations for training, nutrition, and stress management.
DMA® Monitoring
Tracks metabolic changes over time with low- or high-frequency modes for chronic care or clinical oversight.
Users: Clinicians, biologists
End Users: Patients needing ongoing monitoring
Output: Time-based metabolic data to guide treatment and care.
Patent & Certifications
CE Certification for Electromagnetic Compatibility: completed.
DMA® meets the safety, health, and environmental protection requirements established by the regulations of the European Union (CE for Electromagnetic Compatibility) The CE (electromagnetic compatibility) certification obtained, with the support of the MISTER Consortium (CNR – National Research Council) and the test laboratory ELICA.
MDR Class I certification / ISO 13485: ongoing.
Class I devices are intended for non-diagnostic purposes, allowing the product to enter the market in the shortest possible time.
In parallel, the quality management system (QMS) will be updated to comply with ISO 13485, the international standard for medical device quality systems.
While ISO 13485 is not mandatory for Class I devices, aligning with it at this stage is essential to facilitate future certification upgrades.
MDR Class IIa certification: ongoing.
The second step will be to upgrade the device classification to MDR Class IIa.
This certification will expand the DMA’s intended use, allowing it to serve as a diagnostic support tool for physicians.
Achieving Class IIa status requires a more rigorous technical file and compliance with stricter regulatory requirements.
FDA Clearance: ongoing.
The final step will be obtaining FDA clearance for the Class IIa device.
This will enable commercialization of the DMA device in the United States, ensuring compliance with FDA’s regulatory standards for medical devices.
Curious? Inspired? Join the movement.
Math Biology has everything it takes to become the next health tech unicorn. Now’s your chance to be part of it.